News und Analysen
SolarEdge Technologies Q2 Earnings Call Highlights
Key Points
- Interested in SolarEdge Technologies, Inc.? Here are five stocks we like better.
- SolarEdge returned to profitability: Second-quarter revenue rose 19.6% year over year to $346.2
Palomar Q2 Earnings Call Highlights
Key Points
- Interested in Palomar Holdings, Inc.? Here are five stocks we like better.
- Record Q2 results: Adjusted net income rose 31% year over year to $63.8 million, while gross written premium
Commercial Metals Targets $1.8B EBITDA, Expands Construction Solutions Strategy
Key Points
- Interested in Commercial Metals Company? Here are five stocks we like better.
- Commercial Metals targets significant growth by fiscal 2029, including core EBITDA of $1.65 billion to
One Stop Systems Q2 Earnings Call Highlights
Key Points
- Interested in One Stop Systems, Inc.? Here are five stocks we like better.
- Strong growth and raised outlook: Second-quarter revenue from continuing operations rose 62.3% to $9.3
Consumer Portfolio Services Q2 Earnings Call Highlights
Key Points
- Interested in Consumer Portfolio Services, Inc.? Here are five stocks we like better.
- Loan originations surged: Second-quarter originations rose more than 40% sequentially to $758
VanEck Semiconductor ETF: Musk nennt Speicherchips als KI-Engpass
Elon Musk hat den neuen Flaschenhals der Künstlichen Intelligenz ausgemacht. Laut dem SpaceX-Chef limitiert…
Der Beitrag VanEck Semiconductor ETF: Musk nennt Speicherchips als KI-Engpass erschien
Medline Q2 Earnings Call Highlights
Key Points
- Interested in Medline? Here are five stocks we like better.
- Medline reported strong second-quarter growth, with net sales up 12% to $7.7 billion, led by a 16% increase in Supply
CorVel Q1 Earnings Call Highlights
Key Points
- Interested in CorVel Corp.? Here are five stocks we like better.
- CorVel reported strong fiscal first-quarter results: Revenue rose 11% year over year to $260 million, EPS increased
Ferroglobe Q2 Earnings Call Highlights
Key Points
- Interested in Ferroglobe PLC? Here are five stocks we like better.
- Ferroglobe’s Q2 performance improved sequentially: Shipments rose 7% to 188,000 tons, revenue increased 9% to $379
Gladstone Capital Q3 Earnings Call Highlights
Key Points
- Interested in Gladstone Capital Corporation? Here are five stocks we like better.
- Gladstone Capital reported $11 million in third-quarter net investment income, or $0.49 per share
EQS-News: DocCheck Gruppe: Vorläufige Zahlen zum ersten Halbjahr 2026
EQS-News: DocCheck Gruppe: Vorläufige Zahlen zum ersten Halbjahr 2026
Zeotap führt eine durchgängige, modulare CDP-Native-App auf dem Snowflake Marketplace ein
Zeotap betreibt nun die gesamte CDP – Identität, Segmentierung, Orchestrierung und Aktivierung – nativ im eigenen Snowflake-Konto des Kunden, ohne Kopieren und ohne Datenverschiebung
LONDON, Aug
Zeotap führt eine durchgängige, modulare CDP-Native-App auf dem Snowflake Marketplace ein
Zeotap betreibt nun die gesamte CDP – Identität, Segmentierung, Orchestrierung und Aktivierung – nativ im eigenen Snowflake-Konto des Kunden, ohne Kopieren und ohne Datenverschiebung
LONDON, Aug
FTC Solar Q2 Earnings Call Highlights
Key Points
- Interested in FTC Solar, Inc.? Here are five stocks we like better.
- Revenue growth accelerated: FTC Solar reported second-quarter revenue of $26.2 million, up 51.5% sequentially and
Freshpet Q2 Earnings Call Highlights
Key Points
- Interested in Freshpet, Inc.? Here are five stocks we like better.
- Freshpet delivered strong second-quarter results: Net sales rose 15.5% to $305.6 million, adjusted EBITDA increased
Extreme Networks Q4 Earnings Call Highlights
Key Points
- Interested in Extreme Networks, Inc.? Here are five stocks we like better.
- Strong Q4 performance: Extreme Networks reported fiscal Q4 revenue of $339 million, up 10% year over year
Caesarstone Q2 Earnings Call Highlights
Key Points
- Interested in Caesarstone Ltd.? Here are five stocks we like better.
- Profitability improved despite weaker sales: Second-quarter revenue fell 4.5% year over year to $96.6 million
CPS Technologies Q2 Earnings Call Highlights
Key Points
- Interested in CPS Technologies Corp.? Here are five stocks we like better.
- Second-quarter revenue rose modestly to $8.3 million from $8.1 million a year earlier, while gross margin
EQS-Adhoc: Deutsche Rohstoff AG: Erhöhung der Prognose 2026 und 2027 und Ausweitung des Bohrprogramms, EBITDA 2026 steigt auf bis zu 400 Mio. EUR
EQS-Adhoc: Deutsche Rohstoff AG: Erhöhung der Prognose 2026 und 2027 und Ausweitung des Bohrprogramms, EBITDA 2026 steigt auf bis zu 400 Mio. EUR
EQS-Adhoc: Müller - Die lila Logistik SE: Müller - Die Lila Logistik SE beschließt Vorbereitung des Wechsels vom regulierten Markt in das Börsensegment Scale
EQS-Adhoc: Müller - Die lila Logistik SE: Müller - Die Lila Logistik SE beschließt Vorbereitung des Wechsels vom regulierten Markt in das Börsensegment Scale
Azenta Q3 Earnings Call Highlights
Key Points
- Interested in Azenta, Inc.? Here are five stocks we like better.
- Azenta exceeded its third-quarter fiscal 2026 outlook, reporting $161 million in revenue, up 12% year over year and 9%
Astec Industries Q2 Earnings Call Highlights
Key Points
- Interested in Astec Industries, Inc.? Here are five stocks we like better.
- Record Q2 results: Revenue rose 23.6% year over year to $408.1 million, while adjusted EBITDA increased 26%
Kontron Aktie: Ennoconn-Angebot mit 19,5 Prozent gescheitert
Das Pflichtangebot der taiwanischen Ennoconn Corporation für Kontron ist gescheitert. Nur 12.289.840 Aktien wurden…
Der Beitrag Kontron Aktie: Ennoconn-Angebot mit 19,5 Prozent gescheitert erschien
Geron Q2 Earnings Call Highlights
Key Points
- Interested in Geron Corporation? Here are five stocks we like better.
- Geron reported strong second-quarter performance, with revenue rising 17% year over year to $57.5 million and
Compass Pathways Q2 Earnings Call Highlights
Key Points
- Interested in Compass Pathways PLC Sponsored ADR? Here are five stocks we like better.
- Compass Pathways remains on track to file for FDA approval of COMP360 for treatment-resistant